Literature DB >> 17999184

Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study.

Shinobu Imagawa1, Masaharu Yoshihara, Masanori Ito, Shigeto Yoshida, Yoshihiro Wada, Masana Tatsugami, Akemi Takamura, Shinji Tanaka, Ken Haruma, Kazuaki Chayama.   

Abstract

We evaluated the topography of histological gastritis, which may be risk factors for gastric cancer (GCa). A total of 530 Helicobacter pylori-positive patients underwent diagnostic upper-gastrointestinal endoscopy. Biopsy specimens were obtained from the gastric antrum and body to assess the grade of gastritis. Subjects were divided into four groups by the topography of active gastritis (antrum predominant gastritis, AP; pan-gastritis with or without corpus atrophy, Pan-1 and Pan-2; and corpus predominant gastritis, CP). A higher prevalence of GCa followed the order of Pan 2-->CP-->Pan 1-->AP. The age of patients decreased in the same order. When we set Pan 2 and CP as a high-risk group, the sensitivity and specificity for GCa detection were 77.3 and 54.7%, which were superior to the serum criteria using pepsinogens. These suggest that topography of histologic gastritis is an important marker to identify the high-risk group.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999184     DOI: 10.1007/s10620-007-0077-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer.

Authors:  M Miyamoto; K Haruma; M Yoshihara; M Sumioka; T Nishisaka; S Tanaka; K Inoue; K Chayama
Journal:  Dig Liver Dis       Date:  2002-11       Impact factor: 4.088

2.  Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis.

Authors:  X Y Chen; R W van der Hulst; M J Bruno; A van der Ende; S D Xiao; G N Tytgat; F J Ten Kate
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

3.  Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients.

Authors:  T Goto; K Haruma; Y Kitadai; M Ito; M Yoshihara; K Sumii; N Hayakawa; G Kajiyama
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

4.  Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology.

Authors:  K Komoto; K Haruma; T Kamada; S Tanaka; M Yoshihara; K Sumii; G Kajiyama; N J Talley
Journal:  Am J Gastroenterol       Date:  1998-08       Impact factor: 10.864

5.  Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.

Authors:  H Väänänen; M Vauhkonen; T Helske; I Kääriäinen; M Rasmussen; H Tunturi-Hihnala; J Koskenpato; M Sotka; M Turunen; R Sandström; M Ristikankare; A Jussila; P Sipponen
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 2.566

6.  Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum.

Authors:  S Kim; K Harum; M Ito; S Tanaka; M Yoshihara; K Chayama
Journal:  Dig Liver Dis       Date:  2004-04       Impact factor: 4.088

7.  Serum pepsinogen in screening for gastric cancer.

Authors:  A Kodoi; M Yoshihara; K Sumii; K Haruma; G Kajiyama
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

8.  Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma.

Authors:  Hiroyuki Nishibayashi; Shuji Kanayama; Tatsuya Kiyohara; Karsumi Yamamoto; Yoshiji Miyazaki; Yuichi Yasunaga; Yasuhisa Shinomura; Tatsuya Takeshita; Toru Takeuchi; Kanehisa Morimoto; Yuji Matsuzawa
Journal:  J Gastroenterol Hepatol       Date:  2003-12       Impact factor: 4.029

9.  Helicobacter pylori infection, serum gastrin, and gastric acid secretion in teen-age subjects with duodenal ulcer, gastritis, or normal mucosa.

Authors:  K Haruma; H Kawaguchi; K Kohmoto; S Okamoto; M Yoshihara; K Sumii; G Kajiyama
Journal:  Scand J Gastroenterol       Date:  1995-04       Impact factor: 2.423

10.  Helicobacter pylori infection is the major risk factor for atrophic gastritis.

Authors:  H Kawaguchi; K Haruma; K Komoto; M Yoshihara; K Sumii; G Kajiyama
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

View more
  10 in total

Review 1.  Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase.

Authors:  Penny L Jeffery; Michael A McGuckin; Sara K Linden
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

2.  Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histologic risk index.

Authors:  Min Sun Kwak; Nayoung Kim; Hye Seung Lee; Hee Eun Lee; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2010-03-20       Impact factor: 3.199

3.  H. pylori infection is a key risk factor for proximal gastric cancer.

Authors:  Jan Bornschein; Michael Selgrad; Maren Warnecke; Doerthe Kuester; Thomas Wex; Peter Malfertheiner
Journal:  Dig Dis Sci       Date:  2010-07-29       Impact factor: 3.199

4.  Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study.

Authors:  Tung L Nguyen; Tomohisa Uchida; Yoshiyuki Tsukamoto; Dung T Trinh; Long Ta; Bang H Mai; Song H Le; Ky D Thai; Dung D Ho; Hai H Hoang; Takeshi Matsuhisa; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami; Toshio Fujioka; Yoshio Yamaoka; Masatsugu Moriyama
Journal:  BMC Gastroenterol       Date:  2010-09-30       Impact factor: 3.067

5.  Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients.

Authors:  Shunsuke Takata; Masanori Ito; Yoshihiro Wada; Masaharu Yoshihara; Shinji Tanaka; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-04-04       Impact factor: 7.527

6.  The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology.

Authors:  Marcis Leja; Limas Kupcinskas; Konrads Funka; Agnese Sudraba; Laimas Jonaitis; Audrius Ivanauskas; Dainius Janciauskas; Gediminas Kiudelis; Han-Mo Chiu; Jaw-Town Lin
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

7.  Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.

Authors:  Dariush Nasrollahzadeh; Karim Aghcheli; Masoud Sotoudeh; Ramin Shakeri; E Christina Persson; Farhad Islami; Farin Kamangar; Christian C Abnet; Paolo Boffetta; Lars Engstrand; Sanford M Dawsey; Reza Malekzadeh; Weimin Ye
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

8.  Analysis of risks of gastric cancer by gastric mucosa among Indonesian ethnic groups.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Ari Fahrial Syam; Iswan Abbas Nusi; I Dewa Nyoman Wibawa; Yudith Annisa Ayu Rezkitha; Gontar Siregar; O K Yulizal; Fardah Akil; Willy Brodus Uwan; David Simanjuntak; Jimmy Bradley Waleleng; Alexander Michael Joseph Saudale; Fauzi Yusuf; Hasan Maulahela; Marselino Richardo; Abdul Rahman; Yoma Sari Namara; Eko Sudarmo; Pangestu Adi; Ummi Maimunah; Poernomo Boedi Setiawan; Kartika Afrida Fauzia; Dalla Doohan; Tomohisa Uchida; Maria Inge Lusida; Yoshio Yamaoka
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

Review 9.  Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.

Authors:  Sun-Young Lee
Journal:  Korean J Intern Med       Date:  2016-09-01       Impact factor: 2.884

10.  Endoscopy-based Kyoto classification score of gastritis related to pathological topography of neutrophil activity.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Shuntaro Yoshida; Yoshiki Sakaguchi; Yousuke Nakai; Hidenobu Watanabe; Hidekazu Suzuki; Chizu Tanikawa; Koichi Matsuda; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.